Capgemini has created a Pharmaceutical RFID Global Center of Excellence to provide pharmaceutical firms with an integrated solution to help pilot drug pedigree technology and eliminate counterfeit drugs.
Capgemini and software vendor SupplyScape have entered into a joint initiative to deliver an open, secure development environment to test anti-counterfeiting radio frequency identification (RFID) pilots at Capgemini's RFID Center of Excellence in Cambridge, Mass. The initiative allows pharmaceutical companies to pilot their drug pedigree authentication programs. Alternatively, clients can port this technology to their own location to work through their individual business issues.
"Counterfeit drugs don't just create a patient safety issue, they are also a serious business problem," said Paul Nannetti, global life sciences leader for Capgemini. "By maximizing brand security within the proposed FDA timeline, the pharmaceutical industry can meet its obligations and achieve significant return on investment, as well as improvements in efficiency and accuracy."
The RFID Center of Excellence uses hardware and software to enable pharmaceutical companies to create individualized solutions for combating drug counterfeiting in compliance with the recommendations of the U.S. Food & Drug Administration, as well as the requirements of the states of Florida and Nevada.
"Through our special relationship with SupplyScape, we can assist clients in providing the environment for authentication pilots," said Derek Crates, global leader for life science technology solutions for Capgemini. "We're confident that our relationship with SupplyScape will enable us to implement standards and procedures to help combat drug counterfeiting business problems industry-wide."
Recently Sun Microsystems and ADT Security Systems, a division of Tyco Fire & Security Capgemini partners, joined in the development of the RFID Center of Excellence
http://www.capgemini.com/life
